With shares of Yum! Brands (NYSE:YUM) trading at around $67.20, is YUM an OUTPERFORM, WAIT AND SEE or STAY AWAY? Let�� analyze the stock with the relevant sections of our CHEAT SHEET investing framework:
C = Catalyst for the Stock�� Movement
Yum! Brands has 39,000 restaurants in 125 countries, and it shows no signs of stopping there. With strong brand names like KFC, Pizza Hut, and Taco Bell, international potential is still strong. However, the recent ��oor chicken quality��drama in China was a setback. Yum! Brands relies heavily on China, which can be looked at as a positive or a negative. At this exact moment, it�� a negative because Yum! Brands must spend time and money on quality reassurance in China. Let�� take a look at some overall positives and negatives for Yum! Brands.
NEW! Discover a new stock idea each week for less than the cost of 1 trade. CLICK HERE for your Weekly Stock Cheat Sheets NOW!Positives:
Analysts like the stock: 12 Buy, 12 Hold, 1 Sell Comps increased 2 percent in the U.S. (mostly thanks to Taco Bell) Comps increased 1 percent for Yum! Restaurants International Share repurchase program Management confident in a rebound in 2014Negatives:
Top 10 Long Term Companies To Buy Right Now: Sonus Networks Inc.(SONS)
Sonus Networks, Inc. provides voice and multimedia infrastructure solutions. The company offers session border control (SBC), voice over Internet protocol (VoIP), and access and VoIP media gateway solutions that allow the delivery of voice and multimedia sessions over IP networks. Its products include GSX9000 Open Services Switch that enables voice traffic to be transported over packet networks; GSX4000 Open Services Switch; NBS9000 Network Border Switch that permits service providers to transform their time division multiplexing networks to IP; PSX Policy & Routing Server, which translates business policies into actual call control, routing, and service selection decisions; NBS5200 Network Border Switch that provides SBC functionality; and ASX Call Feature Server that provides local area calling and regulatory features for residential and enterprise markets. The company also offers Network Analytics Suite of performance management products, including NetScore network perf ormance analysis tool, NetAssure voice quality monitoring tool, and NetEng network audit and visualization engine that are used for the collection, monitoring, reporting, and notification of performance metrics. In addition, it provides professional consulting and services to support its IP communication solutions; and program management, network deployment design, softswitch and subscriber database design, network verification and audit, custom application and adaptor development, OSS and API integration, migration and upgrade, and managed services. The company serves long-distance and local exchange carriers, Internet service providers, wireless operators, cable operators, financial institutions, retailers, state and local governments, and multinational corporations. It sells its products primarily through a direct sales force in the United States, Europe, the Asia-Pacific, and the Middle East. Sonus Networks, Inc. was founded in 1997 and is headquartered in Westford, Mass achusetts.
Advisors' Opinion:- [By Roberto Pedone]
One networking player that's starting to move within range of triggering a big breakout trade is Sonus Networks (SONS), which provides networked solutions for communications service providers and enterprises in the U.S., Europe, the Middle East, Africa, and the Asia Pacific. This stock has been red hot so far in 2013, with shares up 104%.
If you take a look at the chart for Sonus Networks, you'll notice that this stock has been trending sideways for the past month, with shares moving between $3.25 on the downside and $3.72 on the upside. Shares of SONS have been finding support over the last month each time the stock has pulled back to its 50-day moving average. This stock is now starting to trend a bit higher and move within range of triggering a breakout trade above the upper-end of its sideways consolidating chart pattern.
Traders should now look for long-biased trades in SONS if it manages to break out above some near-term overhead resistance at $3.56 to $3.59 a share and then once it takes out its 52-week high at $3.72 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average action of 2.50 million shares. If that breakout hits soon, then SONS will set up to enter new 52-week high territory, which is bullish technical price action. Some possible upside targets off that breakout are $5 to $5.50 a share.
Traders can look to buy SONS off any weakness to anticipate that breakout and simply use a stop that sits right below some key near-term support levels at $3.33 to $3.25 a share, or right below more support at $3.10 a share. One could also buy SONS off strength once it takes out those breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.
- [By Lee Jackson]
Sonus Networks Inc. (NASDAQ: SONS) was recently named to the 2013 InformationWeek 500 list of top technology innovators across the country. In July the company authorized a repurchase program to buy back up to $100 million of their stock. Lazard has a Buy rating on the stock and a $4.50 price target. The consensus target is at $4.30, and the stock closed yesterday at $3.41.
- [By Evan Niu, CFA]
What: Shares of Sonus Networks (NASDAQ: SONS ) have popped today by upwards of 17% after the company reported first-quarter earnings.
So what: First quarter sales totaled $63.3 million, which turned into a non-GAAP net loss of $0.02 per share. Investors were expecting just $61.1 million up top and an adjusted loss of $0.03 per share, meaning the figures were a beat relative to consensus estimates. Session border controller, or SBC, revenue was up 77% to $30 million.
- [By Ben Fox Rubin]
Sonus Networks Inc.(SONS) agreed to buy Performance Technologies Inc.(PTIX), a supplier of network communications products, for $3.75 a share, a 26% premium of Thursday’s close, or $42 million. The companies said the deal was worth $30 million, net of Performance Technologies’ cash and excluding acquisition costs. Performance Technologies shares jumped 24% to $3.70 premarket, just under the offer price.
Top 10 Quality Companies To Own For 2014: Dycom Industries Inc.(DY)
Dycom Industries, Inc. provides specialty contracting services in the United States and Canada. The company?s services include engineering services, which comprise the design of service area concept boxes, terminals, buried and aerial drops, transmission and central office equipment, administration of feeder and distribution cable pairs, and fiber cable routing and design for telephone companies; and make-ready studies, strand mapping, field walk-out, computer-aided radio frequency design and drafting, and fiber cable routing and design for cable television multiple system operators. The company also provides construction, maintenance, and installation of splice fiber, copper, and coaxial cables to telephone companies; installation and maintenance of customer premise equipment, including set top boxes and cable modems to cable television multiple system operators; and premise wiring services, which include installation, repair, and maintenance of telecommunications infrast ructure within improved structures to various corporations, and state and local governments. In addition, Dycom offers underground utility locating services, such as locating telephone, cable television, power, water, sewer, and gas lines to various utility companies. Further, it provides construction and maintenance services for electric utilities and others, which include installing and maintaining overhead and underground power distribution lines, as well as maintenance and installation of underground natural gas transmission and distribution systems. The company was founded in 1969 and is based in Palm Beach Gardens, Florida.
Advisors' Opinion:- [By Brian Pacampara]
What: Shares of telecom contractor Dycom Industries (NYSE: DY ) climbed 11% today after its quarterly results and outlook topped Wall Street expectations.
- [By Seth Jayson]
Calling all cash flows
When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on Dycom Industries (NYSE: DY ) , whose recent revenue and earnings are plotted below. - [By Seth Jayson]
Dycom Industries (NYSE: DY ) reported earnings on May 21. Here are the numbers you need to know.
The 10-second takeaway
For the quarter ended April 27 (Q3), Dycom Industries beat expectations on revenues and beat expectations on earnings per share.
Top 10 Quality Companies To Own For 2014: Digicore Holdings Ltd (DGC)
Digicore Holdings Limited is a South Africa-based holding company engaged in the manufacturing and distribution of fleet management and vehicle tracking solutions. The Company operates in three segments: South African Distribution, Foreign Distribution, Product Development and Manufacturing and Group Management. The Company's South African distribution segment focuses on distribution of manufactured fleet management and vehicle tracking solutions within the South African consumer market. Foreign distribution focuses on the distribution of manufactured fleet management and vehicle tracking solutions all around the world. Product development and manufacturing segment focuses on investing in research, manufacturing and development of vehicle tracking and fleet management solutions for distribution. Group Management segment renders management services to the Company. On August 31, 2012, the Company obtained an additional 27% shareholding in Ctrack (Pty) Ltd. Advisors' Opinion:- [By Eric Lam]
Detour Gold (DGC) plunged 18 percent to C$6.35, an almost five-year low. The company said in a statement it will not reach its 2013 production target of 270,000 ounces of gold and now forecasts 240,000 to 260,000 ounces.
Top 10 Quality Companies To Own For 2014: Korian SA (KORI)
Korian SA is a France-based company that operates healthcare facilities and medical establishments. The Company's holdings include residential centers for the elderly (EHPAD), offering permanent social care and medical support; follow-up care and rehabilitation centers, including general and specialized centers. Korian SA's establishments are located in France, Italy and Germany via its subsidiaries, Segesta S.p.A., Phonix GmBH, Reacti Malt SAS, Sas La Normandie, Sa La Bastide de la tourne, Sas Mapadex La Roseraie, among others. In March 8, 2013, it finalized the acquisition of Curanum AG by Korian SA's Korian Deutschland AG. In February 2014, it announced the acquisition of a clinic in Florence and the sale of the psychiatry division in France comprising seven clinics and two nursing homes. Advisors' Opinion:- [By Corinne Gretler]
Korian (KORI) declined 3.8 percent to 24.35 euros. The merger with Medica will create the largest French operator of nursing homes. Medica holders will receive Korian stock valued at about 23.01 euros a share, the companies said in a statement today. That�� 15 percent above Medica�� closing price on Nov. 15. Medica shares added 2.4 percent to 20.50 euros.
Top 10 Quality Companies To Own For 2014: Lynas Corp Ltd (LYSDY)
Lynas Corporation Limited is engaged in integrated extraction and processing of rare earth minerals, primarily in Australia and Malaysia; and development of Rare Earth deposits. The Company is engaged in commercial production and shipments of Rare Earths products. The Company has Temporary Operating Licence (TOL) for its Lynas Advanced Materials Plant (LAMP). The Company�� subsidiary includes Lynas Malaysia Sdn Bdh, Lynas Services Pty Ltd, Mount Weld Holdings Pty Ltd, Mount Weld Mining Pty Ltd, Lynas Africa Holdings Pty Ltd and Lynas Africa Ltd. Lynas Malaysia Sdn Bdh operates and develops advanced material processing plant. Mount Weld Mining Pty Ltd is engaged in development of mining areas of interest and operation of concentration plant. Lynas Africa Ltd is engaged in mineral exploration. Advisors' Opinion:- [By Rich Duprey]
Molycorp also needs to contend with the fact that there's a limited market for the metals it will mine at the same time�Lynas (NASDAQOTH: LYSDY ) is�already out there producing them in Malaysia, let alone what China itself is bringing to the market. To think it can substantially crack the market at a profitable price in sufficient quantities, even if it does become a low (or the lowest) cost producer, is wishful thinking of the highest order.
Top 10 Quality Companies To Own For 2014: Fidelity National Financial Inc. (FNF)
Fidelity National Financial, Inc. provides title insurance, mortgage services, and diversified services in the United States. The company provides title insurance, escrow, and other title related services, including collection and trust activities, trustee’s sales guarantees, recordings, and reconveyances, as well as home warranty insurance to various customers in the residential and commercial market sectors of the real estate industry. It is also involved in the design, manufacture, remanufacture, market, and distribution of aftermarket and original equipment electrical components for automobiles, light trucks, heavy-duty trucks, and other vehicles worldwide. In addition, the company owns and operates restaurants comprising the O'Charley's, Ninety Nine Restaurants, Max & Erma's, Village Inn, Bakers Square, and Stoney River Legendary Steaks concepts in the United States. Fidelity National Financial, Inc. is headquartered in Jacksonville, Florida.
Advisors' Opinion:- [By Rich Duprey]
Title insurance company�Fidelity National Financial (NYSE: FNF ) announced yesterday its third-quarter dividend of $0.16 per share, the same rate it's paid for the past three quarters after raising the payout 14% from $0.14 per share.
Top 10 Quality Companies To Own For 2014: Lexicon Pharmaceuticals Inc.(LXRX)
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery and development of drug candidates for the treatment of various human diseases. The company utilizes gene knockout technologies and an integrated platform of medical technologies to systematically study the physiological and behavioral functions of approximately 5,000 genes in mice and assessed the utility of the proteins encoded by the corresponding human genes as drug targets. Its portfolio of orally-delivered small molecule compounds that have completed or are presently conducting phase 2 clinical trails includes LX4211 for the treatment of type 2 diabetes; LX1031 for the treatment of irritable bowel syndrome and other gastrointestinal disorders; LX1032 for the treatment of the symptoms associated with carcinoid syndrome; and LX2931 for the treatment of rheumatoid arthritis and other autoimmune diseases. The company also develops LX1033, an orally-delivered small molecule compound that is in phase 1 clinical trails for the treatment of irritable bowel syndrome and other gastrointestinal disorders. In addition, it develops three orally-delivered small molecule compounds in preclinical development stage that include LX7101 for treatment of glaucoma; LX5061 for the treatment of osteoporosis; and LX2311 for the treatment of autoimmune diseases. Further, the company has small molecule compounds from various additional drug discovery programs in various stages of preclinical research. It has drug discovery and development collaborations with Bristol-Myers Squibb Company; Genentech, Inc.; N.V. Organon; and Takeda Pharmaceutical Company Limited. The company also has a series of agreements with Symphony Icon, Inc. for the financing of clinical development programs; and an alliance with Nuevolution A/S to access Nuevolution?s Chemetics chemistry technology. Lexicon Pharmaceuticals, Inc. was founded in 1995 and is headquartered in The Woodlands, Texas.
Advisors' Opinion:- [By Stephen Simpson, CFA]
I've owned quite a few biotechs over the years, but Lexicon Pharmaceuticals (LXRX) is maybe one of the most frustrating I've owned. Forget about the company's prior business model of selling gene knockout data to drug developers and its near-death experience about five years ago - the simple fact that the company has some very interesting clinical candidates but can't get much love or attention from prospective partners is plenty frustrating in its own right.
- [By Bryan Murphy]
Over the past few weeks, Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) and Decision Diagnostics Corp. (OTCBB:DECN) have dominated the diabetes diagnostics and diabetes treatment landscape. Shares of LXRX jumped 20% on Tuesday following news that one of the key drugs in its pipeline showed more than enough efficacy in its clinical trials. DECN shares are up more than 250% on the heels of an almost-assured victory in its patent lawsuit against industry giant Johnson & Johnson (NYSE:JNJ). Anyone looking for a new trade in the diabetes diagnostics space, however, may want to look past overbought Lexicon Pharmaceuticals and Decision Diagnostics at this point, and instead turn their attention to newly-budding Neurometrix Inc. (NASDAQ:NURO).
- [By Luke Jacobi]
Lexicon Pharmaceuticals (NASDAQ: LXRX) shot up 21.43 percent to $2.89 on kidney-drug data.
Myriad Genetics (NASDAQ: MYGN) rose 7.70 percent to $25.31 after the company reported that CPT code pricing error should take a 'week or two' to correct. Ladenburg Thalmann upgraded the stock from Neutral to Buy.
No comments:
Post a Comment